Recombinant human erythropoietin in neonates: guidelines for clinical practice from the French Society of Neonatology

Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie
E LopezFrench Society of Neonatology

Abstract

1/To assess the effectiveness and safety of EPO in reducing red blood cell (RBC) transfusions in preterm infants. 2/To provide guidelines for clinical practice in France. 1/This systematic evidence review is based on PubMed search, Cochrane library. 2/Using French National Authority for Health methods concerning guidelines for clinical practice. Early EPO reduced the risk of RBC transfusions, donor exposure, and the number of transfusions in very preterm infants (LE2). Late EPO reduced the risk of RBC transfusions and the number of transfusions in very preterm infants (LE2). There is no difference between the effectiveness of early and late EPO (LE2). There is no difference between high-dose and low-dose EPO (LE2). The level of evidence is too low to recommend the intravenous route. EPO has no impact on the rate of bronchopulmonary dysplasia, necrotizing enterocolitis (LE3), and retinopathy of prematurity (LE2). The level of evidence is too low to recommend EPO for neuroprotection in very preterm or term infants. EPO to reduce RBC transfusion in very preterm infants is recommended (Level A). The optimal time to start therapy is unknown (Level B). The recommended dose is 750IU/kg/week via three subcutaneous injections for 6weeks...Continue Reading

References

Feb 24, 2000·Journal of Perinatology : Official Journal of the California Perinatal Association·N R NewtonR H Phibbs
Nov 3, 2004·Pediatrics·Robin K OhlsUNKNOWN National Institute of Child Health and Human Development Neonatal Research Network
May 9, 2006·Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus·Mark S BrownRichard F Hamman
Jul 1, 2008·Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus·Kevin K SukElba Fayard
Aug 5, 2008·Pediatrics·Jean-Claude FauchèreHans Ulrich Bucher
Jan 24, 2009·Clinics in Perinatology·Raghavendra Rao, Michael K Georgieff
Jan 27, 2009·Seminars in Perinatology·Nader Bishara, Robin K Ohls
Sep 8, 2009·The Journal of Pediatrics·Olga A ValievaSandra E Juul
Apr 14, 2010·Pediatrics·Heba ElmahdyHany Aly
May 4, 2010·Annals of Neurology·Achim-Peter NeubauerTanja Jungmann
Apr 15, 2011·The Journal of Pediatrics·Amélia Miyashiro Nunes dos SantosUNKNOWN Brazilian Network on Neonatal Research
Feb 19, 2013·Acta Paediatrica·Simonetta CostaLuca Maggio
Dec 11, 2013·The Journal of Pediatrics·Manon J BendersFrank van Bel
May 23, 2014·European Journal of Pediatrics·Xu-Juan XuHong-Lin Chen
Aug 27, 2014·JAMA : the Journal of the American Medical Association·Russia Ha-Vinh LeuchterPetra Susan Hüppi

❮ Previous
Next ❯

Citations

Jul 23, 2016·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·C DollatP-H Jarreau
Feb 19, 2019·The Cochrane Database of Systematic Reviews·Sanjay M Aher, Arne Ohlsson
Jan 29, 2020·The Cochrane Database of Systematic Reviews·Sanjay M Aher, Arne Ohlsson
Jul 19, 2020·Journal of Perinatal Medicine·Katharina Bolte, Rolf F Maier
Jun 11, 2016·Experimental and Therapeutic Medicine·Weibin QiSumin Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.